{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T20:45:30Z","timestamp":1786653930425,"version":"build-2736575974"},"reference-count":40,"publisher":"American Society of Clinical Oncology (ASCO)","issue":"8","content-domain":{"domain":["ascopubs.org"],"crossmark-restriction":true},"short-container-title":["JCO Glob Oncol"],"published-print":{"date-parts":[[2026,8]]},"abstract":"<jats:sec>\n                    <jats:title>PURPOSE<\/jats:title>\n                    <jats:p>\n                      Homologous recombination repair (HRR) pathway defects are critical drivers of hereditary cancers, yet population-specific prevalence data from India remain limited. Current testing practices disproportionately focus on\n                      <jats:italic toggle=\"yes\">BRCA1\/2<\/jats:italic>\n                      , potentially underidentifying patients with other HRR gene variants who could benefit from targeted therapies.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>METHODS<\/jats:title>\n                    <jats:p>\n                      A retrospective observational cohort study was conducted, analyzing 950 consecutive patients who underwent next generation sequencing-based germline testing at the Cancer Genetics Clinic, Mahamana Pandit Madanmohan Malaviya Cancer Centre, Varanasi. The core HRR panel included\n                      <jats:italic toggle=\"yes\">BRCA1<\/jats:italic>\n                      ,\n                      <jats:italic toggle=\"yes\">BRCA2<\/jats:italic>\n                      ,\n                      <jats:italic toggle=\"yes\">PALB2<\/jats:italic>\n                      ,\n                      <jats:italic toggle=\"yes\">RAD51C<\/jats:italic>\n                      ,\n                      <jats:italic toggle=\"yes\">RAD51D<\/jats:italic>\n                      ,\n                      <jats:italic toggle=\"yes\">ATM<\/jats:italic>\n                      ,\n                      <jats:italic toggle=\"yes\">CHEK2<\/jats:italic>\n                      ,\n                      <jats:italic toggle=\"yes\">BRIP1<\/jats:italic>\n                      ,\n                      <jats:italic toggle=\"yes\">BARD1<\/jats:italic>\n                      ,\n                      <jats:italic toggle=\"yes\">RAD50<\/jats:italic>\n                      ,\n                      <jats:italic toggle=\"yes\">NBN<\/jats:italic>\n                      ,\n                      <jats:italic toggle=\"yes\">MRE11<\/jats:italic>\n                      , and\n                      <jats:italic toggle=\"yes\">FANCC<\/jats:italic>\n                      .\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>RESULTS<\/jats:title>\n                    <jats:p>\n                      Of 950 patients analyzed, 364 (38.3%) harbored variants in HRR genes, with 266 (28%) carrying pathogenic\/likely pathogenic (P\/LP) variants\n                      <jats:italic toggle=\"yes\">. BRCA1<\/jats:italic>\n                      was the most frequently altered gene (182\/266, 68.4% of P\/LP variants), followed by\n                      <jats:italic toggle=\"yes\">BRCA2<\/jats:italic>\n                      (37\/266, 13.9%). Combined BRCA1\/2 genetic variants accounted for 219\/266 (82.3 17%) of all P\/LP variants. Non-\n                      <jats:italic toggle=\"yes\">BRCA<\/jats:italic>\n                      HRR genes contributed 47\/266 (17.6%) P\/LP variants, with\n                      <jats:italic toggle=\"yes\">PALB2<\/jats:italic>\n                      being the most common (14\/266, 5.2%). The study identified 98 variants of uncertain significance across the HRR genes.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>CONCLUSION<\/jats:title>\n                    <jats:p>\n                      This large Indian cohort demonstrates a high prevalence of HRR gene alterations, with significant contribution from non-\n                      <jats:italic toggle=\"yes\">BRCA<\/jats:italic>\n                      genes. These findings support the implementation of comprehensive HRR gene panels in Indian populations and highlight the therapeutic implications for poly (ADP-ribose) polymerase inhibitor and platinum-based treatment strategies.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1200\/go-25-00640","type":"journal-article","created":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T19:59:14Z","timestamp":1786651154000},"update-policy":"https:\/\/doi.org\/10.1200\/crossmark","source":"Crossref","is-referenced-by-count":0,"title":["Uncovering Hereditary Risk: Germline Homologous Recombination Repair Variant Spectrum in a Large North Indian Cancer Cohort (INSIGHT-HRR)"],"prefix":"10.1200","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6006-2631","authenticated-orcid":true,"given":"Akhil","family":"Kapoor","sequence":"first","affiliation":[{"name":"Medical Oncology, Mahamana Pandit Madanmohan Malaviya Cancer Centre &amp; Homi Bhabha Cancer Hospital, Tata Memorial Centre, Homi Bhabha National Institute, Varanasi, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-5607-3889","authenticated-orcid":true,"given":"Srushti","family":"Uthale","sequence":"additional","affiliation":[{"name":"Cancer Genetics, Mahamana Pandit Madanmohan Malaviya Cancer Centre &amp; Homi Bhabha Cancer Hospital, Tata Memorial Centre, Homi Bhabha National Institute, Varanasi, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-9337-3107","authenticated-orcid":true,"given":"Anamika","family":"Chain","sequence":"additional","affiliation":[{"name":"Cancer Genetics, Mahamana Pandit Madanmohan Malaviya Cancer Centre &amp; Homi Bhabha Cancer Hospital, Tata Memorial Centre, Homi Bhabha National Institute, Varanasi, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Archi","family":"Rungta","sequence":"additional","affiliation":[{"name":"Cancer Genetics, Tata Memorial Hospital, Tata Memorial Centre, Homi Bhabha National Institute, Mumbai, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-0435-2703","authenticated-orcid":true,"given":"Anjana","family":"Anoop","sequence":"additional","affiliation":[{"name":"Cancer Genetics, Tata Memorial Hospital, Tata Memorial Centre, Homi Bhabha National Institute, Mumbai, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1241-5436","authenticated-orcid":true,"given":"Anuj","family":"Gupta","sequence":"additional","affiliation":[{"name":"Medical Oncology, Mahamana Pandit Madanmohan Malaviya Cancer Centre &amp; Homi Bhabha Cancer Hospital, Tata Memorial Centre, Homi Bhabha National Institute, Varanasi, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7656-8650","authenticated-orcid":true,"given":"Bipinesh","family":"Sansar","sequence":"additional","affiliation":[{"name":"Medical Oncology, Mahamana Pandit Madanmohan Malaviya Cancer Centre &amp; Homi Bhabha Cancer Hospital, Tata Memorial Centre, Homi Bhabha National Institute, Varanasi, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bal Krishna","family":"Mishra","sequence":"additional","affiliation":[{"name":"Medical Oncology, Mahamana Pandit Madanmohan Malaviya Cancer Centre &amp; Homi Bhabha Cancer Hospital, Tata Memorial Centre, Homi Bhabha National Institute, Varanasi, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-8287-6640","authenticated-orcid":true,"given":"Ankita","family":"Pal","sequence":"additional","affiliation":[{"name":"Biostatistics, Mahamana Pandit Madanmohan Malaviya Cancer Centre &amp; Homi Bhabha Cancer Hospital, Tata Memorial Centre, Homi Bhabha National Institute, Varanasi, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-2045-6152","authenticated-orcid":true,"given":"Soumya","family":"Thakkar","sequence":"additional","affiliation":[{"name":"Cancer Genetics, Mahamana Pandit Madanmohan Malaviya Cancer Centre &amp; Homi Bhabha Cancer Hospital, Tata Memorial Centre, Homi Bhabha National Institute, Varanasi, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6405-8282","authenticated-orcid":true,"given":"Rajiv","family":"Sarin","sequence":"additional","affiliation":[{"name":"Radiation Oncology, Tata Memorial Hospital, Tata Memorial Centre, Homi Bhabha National Institute, Mumbai, India"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"233","reference":[{"key":"e_1_3_7_2_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.onc.1207714"},{"key":"e_1_3_7_3_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2005.10.042"},{"key":"e_1_3_7_4_2","doi-asserted-by":"publisher","DOI":"10.1038\/nrm2851"},{"key":"e_1_3_7_5_2","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a016600"},{"key":"e_1_3_7_6_2","doi-asserted-by":"publisher","DOI":"10.1038\/nrc.2015.21"},{"key":"e_1_3_7_7_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2017.7112"},{"key":"e_1_3_7_8_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2006.09.1066"},{"key":"e_1_3_7_9_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1400382"},{"key":"e_1_3_7_10_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.19.01907"},{"key":"e_1_3_7_11_2","doi-asserted-by":"publisher","DOI":"10.1038\/ng.569"},{"key":"e_1_3_7_12_2","doi-asserted-by":"publisher","DOI":"10.1038\/nature03443"},{"key":"e_1_3_7_13_2","doi-asserted-by":"publisher","DOI":"10.1038\/nature03445"},{"key":"e_1_3_7_14_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.aam7344"},{"key":"e_1_3_7_15_2","doi-asserted-by":"publisher","DOI":"10.3332\/ecancer.2024.1744"},{"key":"e_1_3_7_16_2","doi-asserted-by":"publisher","DOI":"10.1038\/s44276-024-00099-x"},{"key":"e_1_3_7_17_2","doi-asserted-by":"publisher","DOI":"10.1001\/jamaoncol.2017.0424"},{"key":"e_1_3_7_18_2","first-page":"394","article-title":"Global cancer statistics 2018: GLOBOCAN estimates","volume":"68","author":"Bray F","year":"2018","unstructured":"Bray F, Ferlay J, Soerjomataram I, et al: Global cancer statistics 2018: GLOBOCAN estimates. CA Cancer J Clin 68:394-424, 2018","journal-title":"CA Cancer J Clin"},{"key":"e_1_3_7_19_2","doi-asserted-by":"publisher","DOI":"10.1038\/gim.2015.30"},{"key":"e_1_3_7_20_2","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/djv214"},{"key":"e_1_3_7_21_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMsr1501341"},{"key":"e_1_3_7_22_2","first-page":"522","article-title":"Profile of pathogenic mutations and evaluation of germline genetic testing criteria in consecutive breast cancer patients","volume":"154","author":"Kumar S","year":"2021","unstructured":"Kumar S, Rana ML, Verma K, et al: Profile of pathogenic mutations and evaluation of germline genetic testing criteria in consecutive breast cancer patients. Indian J Med Res 154:522-532, 2021","journal-title":"Indian J Med Res"},{"key":"e_1_3_7_23_2","first-page":"44","article-title":"Germline mutation profiling in breast cancer patients of Indian origin: Detailed mutation spectrum and its clinical correlation","volume":"148","author":"Chopra N","year":"2018","unstructured":"Chopra N, Kaur V, Singh K, et al: Germline mutation profiling in breast cancer patients of Indian origin: Detailed mutation spectrum and its clinical correlation. Indian J Med Res 148:44-53, 2018","journal-title":"Indian J Med Res"},{"key":"e_1_3_7_24_2","doi-asserted-by":"publisher","DOI":"10.1038\/nature08365"},{"key":"e_1_3_7_25_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajhg.2013.07.006"},{"key":"e_1_3_7_26_2","first-page":"407","article-title":"Contribution of germline mutations in the RAD51B, RAD51C, and RAD51D genes to ovarian cancer","volume":"103","author":"Song H","year":"2011","unstructured":"Song H, Dicks E, Ramus SJ, et al: Contribution of germline mutations in the RAD51B, RAD51C, and RAD51D genes to ovarian cancer. J Natl Cancer Inst 103:407-416, 2011","journal-title":"J Natl Cancer Inst"},{"key":"e_1_3_7_27_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajhg.2018.01.018"},{"key":"e_1_3_7_28_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-019-39525-3"},{"key":"e_1_3_7_29_2","doi-asserted-by":"publisher","DOI":"10.1186\/bcr3332"},{"key":"e_1_3_7_30_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1706450"},{"key":"e_1_3_7_31_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1810858"},{"key":"e_1_3_7_32_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1903387"},{"key":"e_1_3_7_33_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1911440"},{"key":"e_1_3_7_34_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.18.01854"},{"key":"e_1_3_7_35_2","doi-asserted-by":"publisher","DOI":"10.1007\/s12687-025-00849-5"},{"key":"e_1_3_7_36_2","doi-asserted-by":"publisher","DOI":"10.1245\/s10434-021-10870-w"},{"key":"e_1_3_7_37_2","doi-asserted-by":"publisher","DOI":"10.1007\/s10549-018-4726-x"},{"key":"e_1_3_7_38_2","article-title":"Identification and characterization of germline mutations in Indian women with cancer: A tertiary Center next-generation sequencing Study","author":"Dhanda S","year":"2026","unstructured":"Dhanda S, Suryavanshi M, Sharma SK, et al: Identification and characterization of germline mutations in Indian women with cancer: A tertiary Center next-generation sequencing Study. Indian J Med Paediatric Oncol, 2026","journal-title":"Indian J Med Paediatric Oncol"},{"key":"e_1_3_7_39_2","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-025-15360-w"},{"key":"e_1_3_7_40_2","doi-asserted-by":"publisher","DOI":"10.1055\/s-0044-1788727"},{"key":"e_1_3_7_41_2","doi-asserted-by":"publisher","DOI":"10.6004\/jnccn.2020.0017"}],"container-title":["JCO Global Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/ascopubs.org\/doi\/pdfdirect\/10.1200\/GO-25-00640","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T19:59:27Z","timestamp":1786651167000},"score":1,"resource":{"primary":{"URL":"https:\/\/ascopubs.org\/doi\/10.1200\/GO-25-00640"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":40,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2026,8]]}},"alternative-id":["10.1200\/GO-25-00640"],"URL":"https:\/\/doi.org\/10.1200\/go-25-00640","relation":{},"ISSN":["2687-8941"],"issn-type":[{"value":"2687-8941","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"2025-11-02","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-05-04","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-05-30","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-08-13","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"e2500640"}}